Skip to main content
SpringerLink
Log in

Voluntary Attention and Quality of Life in Patients With Type 1 and Type 2 Diabetes Mellitus: Differences in Changes Depending on Disease Type and Duration

  • Experimental Papers
  • Published:
Journal of Evolutionary Biochemistry and Physiology Aims and scope Submit manuscript

Abstract

This article covers the study of cognitive processes in patients with type 1 and type 2 diabetes mellitus (DM) with disease duration of < 6 years, 6–10 years and > 10 years. In this study a modified analog of the d2 Test—“Clocks Carrousel” Test and SF-36 questionnaire for a self-assessment of quality of life were used. A mild cognitive impairment, namely, decrease in the level of voluntary attention, and a reduced quality of life were found in patients with type 1 and type 2 DM. It was shown that the duration of the disease affects the cognitive processes in DM patients. However, the changes differ in nature depending on the type of diabetes. In patients with T1DM the stability and some improvement of attention characteristics was observed with an increase in disease duration. The revealed changes in attention characteristics in patients with T2DM indicated some decrease in the level of voluntary attention with an increase in disease duration. The comparative analysis showed that the patients with T1DM had a lower level of attention compared with patients with T2DM. These differences were more expressed in patients with disease duration of < 6 years. The SF-36 test results revealed the same tendency of changes in mental status of the patients with DM depending on type and disease duration as changes in the characteristics of voluntary attention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https://www.diabetesatlas.org

  2. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care. 37 (Suppl 1):S81–90. https://doi.org/10.2337/dc14-S081

    Article  Google Scholar 

  3. Leung WK, Gao L, Siu PM, Lai CW (2016) Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study. Life Sci 166:121–130. https://doi.org/10.1016/j.lfs.2016.10.015

    Article  CAS  PubMed  Google Scholar 

  4. Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16(7):377–390. https://doi.org/10.1038/s41581-020-0278-5

    Article  PubMed  Google Scholar 

  5. Kawamura T, Umemura T, Hotta N (2012) Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig 3(5):413–423. https://doi.org/10.1111/j.2040-1124.2012.00234.x

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hamed SA (2017) Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol 10(4):409–428. https://doi.org/10.1080/17512433.2017.1293521

    Article  CAS  PubMed  Google Scholar 

  7. Zhou J, Zhang Z, Zhou H, Qian G (2020) Diabetic Cognitive Dysfunction: From Bench to Clinic. Curr Med Chem 27(19):3151–3167. https://doi.org/10.2174/1871530319666190206225635

    Article  CAS  PubMed  Google Scholar 

  8. Moran C, Münch G, Forbes JM, Beare R, Blizzard L, Venn AJ, Phan TG, Chen J, Srikanth V (2015) Type 2 diabetes, skin autofluorescence, and brain atrophy. Diabetes 64(1):279–283. https://doi.org/10.2337/db14-0506

    Article  CAS  PubMed  Google Scholar 

  9. Saedi E, Gheini MR, Faiz F, Arami MA (2016) Diabetes mellitus and cognitive impairments. World J Diabetes 17:412–422. https://doi.org/10.4239/wjd.v7.i17.412

    Article  Google Scholar 

  10. Shalimova A, Graff B, Gąsecki D, Wolf J, Sabisz A, Szurowska E, Jodzio K, Narkiewicz K (2019) Cognitive Dysfunction in Type 1 Diabetes Mellitus. J Clin Endocrinol Metab 104(6):2239–2249. https://doi.org/10.1210/jc.2018-01315

    Article  PubMed  Google Scholar 

  11. Tamura Y, Araki A (2015) Diabetes mellitus and white matter hyperintensity. Geriatr Gerontol Int 15 (Suppl 1):34–42. https://doi.org/10.1111/ggi.12666

    Article  PubMed  Google Scholar 

  12. Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL, Flores VL, Hoogenboom WS (2012) Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61(9):2375–2379. https://doi.org/10.2337/db11-1669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lee JH, Choi Y, Jun C, Hong YS, Cho HB, Kim JE, Lyoo IK (2014) Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab (Seoul) 29(2):112–121. https://doi.org/10.3803/EnM.2014.29.2.112

  14. Zhang H, Hao Y, Manor B, Novak P, Milberg W, Zhang J, Fang J, Novak V (2015) Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes 64(3):1025–1034. https://doi.org/10.2337/db14-1000

    Article  CAS  PubMed  Google Scholar 

  15. Yang SQ, Xu ZP, Xiong Y, Zhan YF, Guo LY, Zhang S, Jiang RF, Yao YH, Qin YY, Wang JZ, Liu Y, Zhu WZ (2016) Altered Intranetwork and Internetwork Functional Connectivity in Type 2 Diabetes Mellitus With and Without Cognitive Impairment. Sci Rep 6:32980. https://doi.org/10.1038/srep32980

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64(4):570–575. https://doi.org/10.1001/archneur.64.4.570

    Article  PubMed  Google Scholar 

  17. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC (2008) Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 65(8):1066–1073. https://doi.org/10.1001/archneur.65.8.1066

    Article  PubMed  PubMed Central  Google Scholar 

  18. Musen G, Tinsley LJ, Marcinkowski KA, Pober D, Sun JK, Khatri M, Huynh R, Lu A, King GL, Keenan HA (2018) Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications. Diabetes Care 41(8):1749–1756. https://doi.org/10.2337/dc17-1955

    Article  PubMed  PubMed Central  Google Scholar 

  19. Pelimanni E, Jehkonen M (2019) Type 2 Diabetes and Cognitive Functions in Middle Age: A Meta-Analysis. J Int Neuropsychol Soc 25(2):215–229. https://doi.org/10.1017/S1355617718001042

    Article  PubMed  Google Scholar 

  20. Samoilova YG, Rotkank MA, Zhukova NG, Matveeva MV, Tolmachev IV, Kudlay DA (2018) Markers for cognitive impairments and variability of glycaemia in patients with type 1 diabetes mellitus. Zh Nevrol Psikhiatr Im S S Korsakova 118(4):48–51. https://doi.org/10.17116/jnevro20181184148-51

    Article  PubMed  Google Scholar 

  21. Moheet A, Mangia S, Seaquist ER (2015) Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci 1353:60–71. https://doi.org/10.1111/nyas.12807

    Article  PubMed  PubMed Central  Google Scholar 

  22. Embury CM, Wiesman AI, McDermott TJ, Proskovec AL, Heinrichs-Graham E, Lord GH, Brau KL, Drincic AT, Desouza CV, Wilson TW (2019) The impact of type 1 diabetes on neural activity serving attention. Hum Brain Mapp 40(4):1093–1100. https://doi.org/10.1002/hbm.24431

    Article  PubMed  Google Scholar 

  23. Zhang YW, Zhang JQ, Liu C, Wei P, Zhang X, Yuan QY, Yin XT, Wei LQ, Cui JG, Wang J (2015) Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes. Chin Med J (Engl) 128(4):465–471. https://doi.org/10.4103/0366-6999.151082

  24. Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW (2016) Diabetes and Cognitive Impairment. Curr Diab Rep 16(9):87. https://doi.org/10.1007/s11892-016-0775-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ding X, Fang C, Li X, Cao YJ, Zhang QL, Huang Y, Pan J, Zhang X (2019) Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: results from a prospective cross-sectional study. BMC Endocr Disord 19(1):34. https://doi.org/10.1186/s12902-019-0359-2

    Article  PubMed  PubMed Central  Google Scholar 

  26. Roy S, Kim N, Desai A, Komaragiri M, Baxi N, Jassil N, Blessinger M, Khan M, Cole R, Desai N, Terrigno R, Hunter K (2015) Cognitive Function and Control of Type 2 Diabetes Mellitus in Young Adults. N Am J Med Sci 7(5):220–226. https://doi.org/10.4103/1947-2714.157627

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sun L, Diao X, Gang X, Lv Y, Zhao X, Yang S, Gao Y, Wang G (2020) Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes. J Diabetes Res 2020:4591938. https://doi.org/10.1155/2020/4591938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gandek B, Sinclair SJ, Kosinski M, Ware JE Jr (2004) Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financ Rev 25(4):5–25.

    PubMed  PubMed Central  Google Scholar 

  29. Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25(24):3130–3139. https://doi.org/10.1097/00007632-200012150-00008

  30. Brickenkamp R (2012) d2, Test de Atención: Manual. Adaptación española: Nicolas Seisdedos Cubero. 4ed. Madrid: TEA Ediciones, S.A.U. I.S.B.N.:978-84-15262-68-8

    Google Scholar 

  31. Sidorov KR (2012) Qualitative Assessment of the Efficiency of Attention in the Methodology of “Cancellation Test” by B. Bourdon. Bull. Udmurt State University 4: 50–57. (In Russ).

    Google Scholar 

  32. Lin J-D, Chen Y-L, Wu C-Z, Hsieh C-H, Pei D, Liang Y-J, Chang J-B (2016) Identification of Normal Blood Pressure in Different Age Group. Medicine (Baltimore) 95(14): e3188. https://doi.org/10.1097/MD.0000000000003188

  33. Eguchi K (2015) Blood Pressure Management in Patients with Type 2 Diabetes. Intern Med 54(18):2285–2289. https://doi.org/10.2169/internalmedicine.54.5617

    Article  CAS  PubMed  Google Scholar 

  34. Dederer J, Bewarder Y, Mahfoud F, Böhm M (2019) Blutdruckziele bei Patienten mit Diabetes mellitus : Was sind optimale Werte? [Blood pressure targets in patients with diabetes mellitus : What are optimum values?]. Herz 44(3):231–237. German. https://doi.org/10.1007/s00059-019-4796-5

    Article  CAS  PubMed  Google Scholar 

  35. Mokhtari Z, Gheshlagh RG, Kurdi A (2019) Health-related quality of life in Iranian patients with type 2 diabetes: An updated meta-analysis. Diabetes Metab Syndr 13(1):402–407. https://doi.org/10.1016/j.dsx.2018.10.007

    Article  PubMed  Google Scholar 

  36. Krzemińska S, Bąk E, Šáteková L, Polanská A, Hašová K, Laurinc M (2020) Comparison of Diabetes-Dependent Quality of Life (ADDQoL) in Patients with T2DM in Poland, The Czech Republic, and Slovakia. Diabetes Metab Syndr Obes 13:3773–3786. https://doi.org/10.2147/DMSO.S273339

    Article  PubMed  PubMed Central  Google Scholar 

  37. Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML, Gutierrez-Gonzalez A, Najera-Ahumada AG, Cisneros-González N (2018) Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health Qual Life Outcomes 16(1):94. https://doi.org/10.1186/s12955-018-0906-y

    Article  PubMed  PubMed Central  Google Scholar 

  38. Jing X, Chen J, Dong Y, Han D, Zhao H, Wang X, Gao F, Li C, Cui Z, Liu Y, Ma J (2018) Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis. Health Qual Life Outcomes 16(1):189. https://doi.org/10.1186/s12955-018-1021-9

    Article  PubMed  PubMed Central  Google Scholar 

  39. Abdul-Rasoul M, AlOtaibi F, Abdulla A, Rahme Z, AlShawaf F (2013) Quality of life of children and adolescents with type 1 diabetes in Kuwait. Med Princ Pract 22(4):379–384. https://doi.org/10.1159/000347052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bhavani N, Prince S, Menon AS, Abraham N, Pavithran PV, Menon UV, Nair V, Kumar H (2021) Health related quality of life in pediatric onset Type 1 diabetes mellitus in Kerala, India. Pediatr Diabetes 22(2):369–373. https://doi.org/10.1111/pedi.13151

    Article  PubMed  Google Scholar 

  41. Spasić A, Radovanović R, Đorđević A, Stefanović N, Cvetković T (2014) Quality of Life in Type 2 Diabetic Patients. Acta Facultatis Medicae Naissensis 31(3):193–200. https://doi.org/10.2478/afmnai-2014-0024

    Article  Google Scholar 

  42. Prasanna Kumar HR, Mahesh MG, Menon VB, Srinath KM, Shashidhara KC, Ashok P (2018) Patient Self-reported quality of life assessment in Type 2 diabetes mellitus: A pilot study. Niger J Clin Pract 21(3):343–349. https://doi.org/10.4103/njcp.njcp_433_16

    Article  CAS  Google Scholar 

  43. Bąk E, Nowak-Kapusta Z, Dobrzyn-Matusiak D, Marcisz-Dyla E, Marcisz C, Krzemińska SA (2019) An assessment of diabetes-dependent quality of life (ADDQoL) in women and men in Poland with type 1 and type 2 diabetes. Ann Agric Environ Med 26(3):429–438. https://doi.org/10.26444/aaem/99959

    Article  PubMed  Google Scholar 

  44. McCrimmon RJ, Ryan CM, Frier BM (2012) Diabetes and cognitive dysfunction. Lancet 379(9833):2291–2299. https://doi.org/10.1016/S0140-6736(12)60360-2

    Article  PubMed  Google Scholar 

  45. Ryan CM, van Duinkerken E, Rosano C (2016) Neurocognitive consequences of diabetes. Am Psychol 71(7):563–576. https://doi.org/10.1037/a0040455

    Article  PubMed  Google Scholar 

  46. Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591–604. https://doi.org/10.1038/s41574-018-0048-7

    Article  PubMed  PubMed Central  Google Scholar 

  47. Lee HJ, Seo HI, Cha HY, Yang YJ, Kwon SH, Yang SJ (2018) Diabetes and Alzheimer’s Disease: Mechanisms and Nutritional Aspects. Clin Nutr Res 7(4):229–240. https://doi.org/10.7762/cnr.2018.7.4.229

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zhao X, Han Q, Lv Y, Sun L, Gang X, Wang G (2017) Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies. Oncotarget 9(7):7710–7726. https://doi.org/10.18632/oncotarget.23284

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Mayeda ER, Whitmer RA, Yaffe K (2015) Diabetes and cognition. Clin Geriatr Med 31(1):101–115. ix. https://doi.org/10.1016/j.cger.2014.08.021

    Article  PubMed  Google Scholar 

  50. Brismar T, Maurex L, Cooray G, Juntti-Berggren L, Lindström P, Ekberg K, Adner N, Andersson S (2007) Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology 32(8–10):1041–1051. https://doi.org/10.1016/j.psyneuen.2007.08.002

    Article  PubMed  Google Scholar 

  51. Trujeque-Ramos S, Castillo-Rolón D, Galarraga E, Tapia D, Arenas-López G, Mihailescu S, Hernández-López S (2018) Insulin Regulates GABAA Receptor-Mediated Tonic Currents in the Prefrontal Cortex. Front Neurosci 12:345. https://doi.org/10.3389/fnins.2018.00345

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ghasemi R, Haeri A, Dargahi L, Mohamed Z, Ahmadiani A (2013) Insulin in the brain: sources, localization and functions. Mol Neurobiol 47(1):145–171. https://doi.org/10.1007/s12035-012-8339-9

    Article  CAS  PubMed  Google Scholar 

  53. Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14(3):168–181. https://doi.org/10.1038/nrneurol.2017.185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Arvanitakis Z, Wang HY, Capuano AW, Khan A, Taïb B, Anokye-Danso F, Schneider JA, Bennett DA, Ahima RS, Arnold SE (2020) Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol 88(3):513–525. https://doi.org/10.1002/ana.25826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Gaddam M, Singh A, Jain N, Avanthika C, Jhaveri S, De la Hoz I, Sanka S, Goli SR (2021) A Comprehensive Review of Intranasal Insulin and Its Effect on the Cognitive Function of Diabetics. Cureus 13(8):e17219. https://doi.org/10.7759/cureus.17219

    Article  PubMed  PubMed Central  Google Scholar 

  56. Benedict C, Hallschmid M, Schmitz K, Schultes B, Ratter F, Fehm HL, Born J, Kern W (2007) Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32(1):239–243. https://doi.org/10.1038/sj.npp.1301193

    Article  CAS  PubMed  Google Scholar 

  57. Ritze Y, Kern W, Ebner EM, Jahn S, Benedict C, Hallschmid M (2018) Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men. Front Endocrinol (Lausanne) 13(9):663. https://doi.org/10.3389/fendo.2018.00663

  58. Shemesh E, Rudich A, Harman-Boehm I, Cukierman-Yaffe T (2012) Effect of intranasal insulin on cognitive function: a systematic review. J Clin Endocrinol Metab 97(2):366–376. https://doi.org/10.1210/jc.2011-1802

    Article  CAS  PubMed  Google Scholar 

  59. Gao Y, Xiao Y, Miao R, Zhao J, Zhang W, Huang G, Ma F (2015) The characteristic of cognitive function in Type 2 diabetes mellitus. Diabetes Res Clin Pract 109(2):299–305. https://doi.org/10.1016/j.diabres.2015.05.019

    Article  PubMed  Google Scholar 

  60. Jeste DV (2019) Frailty and mental health: association with cognition, sleep, and well-being in older adults. Int Psychogeriatr 31(6):755–757. https://doi.org/10.1017/S1041610219000863

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. L.A. Orbeli Institute of Physiology NAS RA, Yerevan, Armenia

    N. E. Tadevosyan, A. S. Khachunts, A. A. Sahakyan & A. A. Tumanyan

  2. Yasuj University of Medical Sciences, Yasuj, Iran

    M. Gohargani

Authors
  1. N. E. Tadevosyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. Khachunts
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Gohargani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. A. Sahakyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. A. Tumanyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Work idea and experiment planning (T.N.), subject recruitment and data collection (G.M., S.A.), statistical analysis and writing of the manuscript (T.N., T.A.), editing of the manuscript (Kh.A., T.A.).

Corresponding author

Correspondence to A. A. Tumanyan.

Ethics declarations

CONFLICTS OF INTEREST

The authors declare no obvious and potential conflicts of interest relevant to this article.

Additional information

Translated by N. Tadevosyan

Russian Text © The Author(s), 2022, published in Rossiiskii Fiziologicheskii Zhurnal imeni I.M. Sechenova, 2022, Vol. 108, No. 4, pp. 455–473https://doi.org/10.31857/S0869813922040082.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tadevosyan, N.E., Khachunts, A.S., Gohargani, M. et al. Voluntary Attention and Quality of Life in Patients With Type 1 and Type 2 Diabetes Mellitus: Differences in Changes Depending on Disease Type and Duration. J Evol Biochem Phys 58, 569–584 (2022). https://doi.org/10.1134/S0022093022020247

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0022093022020247

Keywords:

Search

Navigation